The reasons include better screening and finding cancers at earlier stages.
These findings are important because they validate recommendations that screening should begin at the age of 20 to 25 for women at risk of hereditary breast and ovarian cancer.
The study appears in the journal "Cancer."
Experts say the results should inspire younger women with BRCA mutations to follow screening guidelines.
